When to evaluate effectiveness?- Anti-CGRPs and gepants
Session 1: New treatments – Evaluation and management
Erling Tronvik
MD, PhD - Scientific Director of NorHEAD, Senior Consultant at St.Olav University Hospital and Professor at Department of Neuromedicine and Movement Science, NTNU - Trondheim, Norway
Previous
Anti-CGRP therapies: similar but not the same
Next